Texas Oncology

Flower Mound, Texas 75028

1 studies enrolling now · 3 studies all time

What they study most

Cancer, Non-Small Cell Lung Cancer, Prostatic Neoplasms, Castration-Resistant

Studies at this site

• Expanded Access for Cancer Treatment With Balstilimab (AGEN2034) and Zalifrelimab (AGEN1884) — Available (expanded access)
• A Study of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate Cancer — Stopped early
• A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC) — Completed